biote Corp.
BTMD
$1.79
-$0.17-8.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -5.63% | -2.52% | 1.34% | 6.32% | 6.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.63% | -2.52% | 1.34% | 6.32% | 6.44% |
| Cost of Revenue | -1.85% | -5.63% | -6.94% | -2.08% | -0.29% |
| Gross Profit | -7.15% | -1.22% | 4.90% | 10.00% | 9.41% |
| SG&A Expenses | -1.75% | 1.39% | 8.44% | 9.29% | 19.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.79% | -1.16% | 2.68% | 5.00% | 11.46% |
| Operating Income | -22.78% | -8.37% | -4.14% | 11.84% | -11.40% |
| Income Before Tax | 7.67% | 3,599.21% | 165.87% | 98.46% | 25.60% |
| Income Tax Expenses | 2,635.33% | 517.22% | -158.11% | -37.28% | -95.87% |
| Earnings from Continuing Operations | -14.70% | 68,589.13% | 275.69% | 129.77% | 67.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -392.17% | -246.32% | -152.51% | 60.41% | 91.71% |
| Net Income | -25.82% | 756.67% | 300.58% | 679.58% | 252.95% |
| EBIT | -22.78% | -8.37% | -4.14% | 11.84% | -11.40% |
| EBITDA | -20.43% | -6.69% | -1.42% | 14.32% | -8.13% |
| EPS Basic | -26.95% | 569.83% | 285.24% | 607.36% | 538.53% |
| Normalized Basic EPS | -42.07% | -47.61% | -16.35% | 143.77% | 48.19% |
| EPS Diluted | -24.31% | 685.10% | 575.64% | 3,235.19% | 6,837.93% |
| Normalized Diluted EPS | -42.21% | -50.11% | -25.04% | 115.56% | 34.59% |
| Average Basic Shares Outstanding | -2.04% | -3.75% | -5.27% | -4.98% | 6.05% |
| Average Diluted Shares Outstanding | -3.08% | -0.74% | -12.62% | -14.71% | -6.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.59% | -0.94% | -0.90% | -0.94% | -0.74% |